These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 34958507

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Histiocytosis - cutaneous manifestations of hematopoietic neoplasm and non-neoplastic histiocytic proliferations.
    Luder CM, Nordmann TM, Ramelyte E, Mühleisen B, Kerl K, Guenova E, Dummer R.
    J Eur Acad Dermatol Venereol; 2018 Jun; 32(6):926-934. PubMed ID: 29341328
    [Abstract] [Full Text] [Related]

  • 3. Rare diseases of bone: Erdheim-Chester and Rosai-Dorfman non-Langerhans cell histiocytoses.
    Mavrogenis AF, Igoumenou VG, Antoniadou T, Megaloikonomos PD, Agrogiannis G, Foukas P, Papageorgiou SG.
    EFORT Open Rev; 2018 Jun; 3(6):381-390. PubMed ID: 30034819
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cutaneous adult xanthogranuloma with a small portion of BRAFV 600E mutated Langerhans cell histiocytosis populations: A case report and the review of published work.
    Ishikawa M, Endo Y, Uehara A, Suto M, Yasuda M, Motegi SI, Ishikawa O.
    J Dermatol; 2019 Feb; 46(2):161-165. PubMed ID: 30536719
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The non-Langerhans' cell histiocytoses in childhood.
    Burgdorf WH, Zelger B.
    Cutis; 1996 Sep; 58(3):201-7. PubMed ID: 8886534
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. MAP2K1-driven mixed Langerhans cell histiocytosis, Rosai-Dorfman-Destombes disease and Erdheim-Chester disease, clonally related to acute myeloid leukemia.
    Bonometti A, Ferrario G, Parafioriti A, Giardino D, Simonetti F, Ginori A, Passoni E, Berti E, for AIRI, Associazione Italiana Ricerca Istiocitosi ONLUS.
    J Cutan Pathol; 2021 May; 48(5):637-643. PubMed ID: 33188581
    [Abstract] [Full Text] [Related]

  • 11. Langerhans cell histiocytosis and juvenile xanthogranuloma. Two case reports.
    Patrizi A, Neri I, Bianchi F, Guerrini V, Misciali C, Paone G, Burnelli R.
    Dermatology; 2004 May; 209(1):57-61. PubMed ID: 15237270
    [Abstract] [Full Text] [Related]

  • 12. Generalized Eruptive Histiocytosis or Juvenile Xanthogranuloma: A Clinicopathological Conundrum of Coexistence or Xanthomatization.
    Murthy AB, Palaniappan V, Selvaarasan J, Karthikeyan K.
    Indian Dermatol Online J; 2024 May; 15(5):828-833. PubMed ID: 39359292
    [Abstract] [Full Text] [Related]

  • 13. Non-Langerhans cell histiocytosis with isolated CNS involvement: an unusual variant of Erdheim-Chester disease.
    Conley A, Manjila S, Guan H, Guthikonda M, Kupsky WJ, Mittal S.
    Neuropathology; 2010 Dec; 30(6):634-47. PubMed ID: 20337948
    [Abstract] [Full Text] [Related]

  • 14. Histiocytosis with mixed cell populations.
    Martín JM, Jordá E, Martín-Gorgojo A, Beteta G, Monteagudo C.
    J Cutan Pathol; 2016 May; 43(5):456-60. PubMed ID: 26968131
    [Abstract] [Full Text] [Related]

  • 15. [Cladribine is highly effective in the treatment of Langerhans cell histiocytosis and rare histiocytic disorders of the juvenile xanthogranuloma group].
    Adam Z, Szturz P, Pour L, Krejčí M, Zahradová L, Tomíška M, Král Z, Koukalová R, Rehák Z, Mayer J.
    Vnitr Lek; 2012 Jun; 58(6):455-65. PubMed ID: 22913238
    [Abstract] [Full Text] [Related]

  • 16. [Cutaneous non-Langerhans cells histiocytoses as cause of central diabetes insipidus].
    Miranda PA, Miranda SM, Bittencourt FV, Machado LJ, Castro LP, Leite VH, Lauria MW, Braga WR, Oliveira AR.
    Arq Bras Endocrinol Metabol; 2007 Aug; 51(6):1018-22. PubMed ID: 17934672
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Treatment of Langerhans Cell Histiocytosis and Histiocytic Disorders: A Focus on MAPK Pathway Inhibitors.
    Geerlinks AV, Abla O.
    Paediatr Drugs; 2023 Jul; 25(4):399-409. PubMed ID: 37204611
    [Abstract] [Full Text] [Related]

  • 19. [An overview of histiocytosis].
    Tojo A.
    Rinsho Ketsueki; 2022 Jul; 63(5):363-367. PubMed ID: 35662158
    [Abstract] [Full Text] [Related]

  • 20. Fetal and neonatal histiocytoses.
    Isaacs H.
    Pediatr Blood Cancer; 2006 Aug; 47(2):123-9. PubMed ID: 16416419
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.